Literature DB >> 6373262

Subgroups of class 1 antiarrhythmic drugs.

E M Vaughan Williams.   

Abstract

Mesh：

Substances：

Year:  1984        PMID： 6373262     DOI： 10.1093/oxfordjournals.eurheartj.a061632

Source DB:  PubMed          Journal:  Eur Heart J        ISSN： 0195-668X            Impact factor:   29.983


× No keyword cloud information.
  14 in total

Review 1.  Subclassification of class I antiarrhythmic drugs: enhanced relevance after CAST.

Authors:  T J Campbell
Journal:  Cardiovasc Drugs Ther       Date:  1992-10       Impact factor: 3.727

2.  Frequency-dependent action of antiarrhythmic drugs: the useful concept of periodical ligand binding.

Authors:  J Weirich
Journal:  Basic Res Cardiol       Date:  1992 May-Jun       Impact factor: 17.165

Review 3.  A Literature Review of the Use of Sodium Bicarbonate for the Treatment of QRS Widening.

Authors:  Rebecca E Bruccoleri; Michele M Burns
Journal:  J Med Toxicol       Date:  2016-03

Review 4.  Adverse effects of class I antiarrhythmic drugs.

Authors:  J Caron; C Libersa
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

Review 5.  Oral loading with propafenone for conversion of recent-onset atrial fibrillation: a review on in-hospital treatment.

Authors:  Giuseppe Boriani; Cristian Martignani; Mauro Biffi; Alessandro Capucci; Angelo Branzi
Journal:  Drugs       Date:  2002       Impact factor: 9.546

6.  Electrophysiological effects of flecainide enantiomers in canine Purkinje fibres.

Authors:  J K Smallwood; D W Robertson; M I Steinberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-06       Impact factor: 3.000

7.  Combined anti-arrhythmic therapy with class 1 and class 3 drugs.

Authors:  M A James; P Papouchado; J V Jones
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

8.  Clinical usefulness of flecainide acetate in the treatment of paroxysmal supraventricular arrhythmias.

Authors:  A J Camm; K J Hellestrand; A W Nathan; R S Bexton
Journal:  Drugs       Date:  1985       Impact factor: 9.546

9.  The proarrhythmic effects of flecainide.

Authors:  A W Nathan; K J Hellestrand; R S Bexton; R A Spurrell; A J Camm
Journal:  Drugs       Date:  1985       Impact factor: 9.546

10.  Different flecainide sensitivity of hNav1.4 channels and myotonic mutants explained by state-dependent block.

Authors:  Jean-François Desaphy; Annamaria De Luca; Maria Paola Didonna; Alfred L George; Diana Camerino Conte; Annamaria D E Luca
Journal:  J Physiol       Date:  2003-11-07       Impact factor: 5.182
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.